![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 17, 2017 3:43:28 PM
I have no idea if any type of cell could be grown in their bioreactor. I have always assumed so and may be wrong, I don't know. So if a competitor was going to pay someone else a large sum of money to produce their cells, why would you not want a piece of that pie. It's getting done either way, so why not. Not saying tweak their cells or help them out in any way like that. But just grow the cells and charge gobs of cash for doing so. Even a small phase 1 or 2 trial, could have brought in millions of dollars. And you would have expanded your manufacturing capability to handle anything Pluristem would need for their own use.
I don't know maybe it's just me. Seems quite logical and maybe I'm way off base. Hence the call for others to give their two cents. So far, only one usual taker.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM